[1] |
WESTERKAMP AC, FUJIYOSHI M, OTTENS PJ, et al. Metformin preconditioning improves hepatobiliary function and reduces injury in a rat model of normothermic machine perfusion and orthotopic transplantation[J]. Transplantation, 2020, 104(9): e271-e280. DOI: 10.1097/TP.0000000000003216.
|
[2] |
代星, 高犇, 李江. 改善脂肪肝移植受者预后的研究进展[J]. 临床肝胆病杂志, 2021, 37(12): 2967-2971. DOI: 10.3969/j.issn.1001-5256.2021.12.049.DAI X, GAO B, LI J. Research advances in improving the prognosis of recipients of fatty liver transplantation[J]. J Clin Hepatol, 2021, 37(12): 2967-2971. DOI: 10.3969/j.issn.1001-5256.2021.12.049.
|
[3] |
张强, 刘勤, 牛春燕. 利拉鲁肽减轻脂毒性肝细胞损伤并促进自噬改善非酒精性脂肪肝[J]. 中华肝脏病杂志, 2021, 29(5): 456-461. DOI: 10.3760/cma.j.cn501113-20200427-00219.ZHANG Q, LIU Q, NIU CY. Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve non-alcoholic fatty liver[J]. Chin J Hepatol, 2021, 29(5): 456-461. DOI: 10.3760/cma.j.cn501113-20200427-00219.
|
[4] |
杨梦凡, 王睿, 潘斌华, 等. 脂肪变性供肝用于肝癌肝移植的预后及影响因素多中心研究[J]. 中华消化外科杂志, 2022, 21(2): 237-248. DOI: 10.3760/cma.j.cn115610-20220209-00072.YANG MF, WANG R, PAN BH, et al. Prognosis and influencing factors of liver transplantation for hepatocellular carcinoma using steatotic donor liver: a multicenter study[J]. Chin J Dig Surg, 2022, 21(2): 237-248. DOI: 10.3760/cma.j.cn115610-20220209-00072.
|
[5] |
MAJUMDAR A, TSOCHATZIS EA. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease[J]. Metabolism, 2020, 111S: 154291. DOI: 10.1016/j.metabol.2020.154291.
|
[6] |
ZHU L, MU J, WU Y, et al. Role of HIF-1α in cold ischemia injury of rat donor heart via the miR-21/PDCD4 pathway[J]. Transplant Proc, 2020, 52(1): 383-391. DOI: 10.1016/j.transproceed.2019.11.001.
|
[7] |
LARGE S, MESSER S. Intra-corporeal recovery of the donor heart after circulatory-determined death followed by cold storage in clinical practice[J]. Eur J Cardiothorac Surg, 2021, 60(4): 820-821. DOI: 10.1093/ejcts/ezab360.
|
[8] |
YOUNG LAJ, CERESA CDL, MÓZES FE, et al. Noninvasive assessment of steatosis and viability of cold-stored human liver grafts by MRI[J]. Magn Reson Med, 2021, 86(6): 3246-3258. DOI: 10.1002/mrm.28930.
|
[9] |
HAMAMOTO I, NEMOTO EM, ZHANG S, et al. Assessment of hepatic viability during cold ischemic preservation[J]. Transpl Int, 1995, 8(6): 434-439. DOI: 10.1007/BF00335594.
|
[10] |
CARDINI B, FODOR M, HERMANN M, et al. Live confocal imaging as a novel tool to assess liver quality: insights from a murine model[J]. Transplantation, 2020, 104(12): 2528-2537. DOI: 10.1097/TP.0000000000003405.
|
[11] |
MCKAY FLETCHER DM, SHAW R, SÁNCHEZ-RODRÍGUEZ AR, et al. Quantifying citrate-enhanced phosphate root uptake using microdialysis[J]. Plant Soil, 2021, 461(1/2): 69-89. DOI: 10.1007/s11104-019-04376-4.
|
[12] |
KIM S, JANG EY, SONG SH, et al. Brain microdialysis coupled to LC-MS/MS revealed that CVT-10216, a selective inhibitor of aldehyde dehydrogenase 2, alters the neurochemical and behavioral effects of methamphetamine[J]. ACS Chem Neurosci, 2021, 12(9): 1552-1562. DOI: 10.1021/acschemneuro.1c00039.
|
[13] |
王进, 王丹, 郇传胜, 等. 脂肪肝大鼠肝脏缺血损伤后透析液葡萄糖、乳酸、丙酮酸、甘油水平变化及意义[J]. 山东医药, 2019, 59(35): 24-28. DOI: 10.3969/j.issn.1002-266X.2019.35.006.WANG J, WANG D, HUAN CS, et al. Changes in levels of serum glucose, lactate, pyruvate and glycerol of steatotic liver rats after hepatic ischemic injury[J]. Shandong Med J, 2019, 59(35): 24-28. DOI: 10.3969/j.issn.1002-266X.2019.35.006.
|
[14] |
CHENG N, SHI JH, JIN Y, et al. Pharmacological activating transcription factor 6 activation is beneficial for liver retrieval with ex vivo normothermic mechanical perfusion from cardiac dead donor rats[J]. Front Surg, 2021, 8: 665260. DOI: 10.3389/fsurg.2021.665260.
|
[15] |
CERESA CDL, NASRALLA D, POLLOK JM, et al. Machine perfusion of the liver: applications in transplantation and beyond[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(3): 199-209. DOI: 10.1038/s41575-021-00557-8.
|
[16] |
KARANGWA S, PANAYOTOVA G, DUTKOWSKI P, et al. Hypothermic machine perfusion in liver transplantation[J]. Int J Surg, 2020, 82S: 44-51. DOI: 10.1016/j.ijsu.2020.04.057.
|
[17] |
TATSIS V, DOUNOUSI E, MITSIS M. Hypothermic machine perfusion of kidney transplant: a mini-review[J]. Transplant Proc, 2021, 53(9): 2793-2796. DOI: 10.1016/j.transproceed.2021.09.011.
|
[18] |
WANG S, ZENG X, YANG Y, et al. Hypothermic oxygenated perfusion ameliorates ischemia-reperfusion injury of fatty liver in mice via Brg1/Nrf2/HO-1 axis[J]. Artif Organs, 2022, 46(2): 229-238. DOI: 10.1111/aor.14076.
|
[19] |
TANEJA C, PRESCOTT L, KONERU B. Critical preservation injury in rat fatty liver is to hepatocytes, not sinusoidal lining cells[J]. Transplantation, 1998, 65(2): 167-172. DOI: 10.1097/00007890-199801270-00004.
|
[20] |
TOLBA RH, PÜTZ U, DECKER D, et al. L-carnitine ameliorates abnormal vulnerability of steatotic rat livers to cold ischemic preservation[J]. Transplantation, 2003, 76(12): 1681-1686. DOI: 10.1097/01.TP.0000093832.15249.AD.
|
[21] |
CHU MJ, HICKEY AJ, JIANG Y, et al. Mitochondrial dysfunction in steatotic rat livers occurs because a defect in complex i makes the liver susceptible to prolonged cold ischemia[J]. Liver Transpl, 2015, 21(3): 396-407. DOI: 10.1002/lt.24024.
|
[22] |
CHU MJ, HICKEY AJ, TAGALOA S, et al. Ob/ob mouse livers show decreased oxidative phosphorylation efficiencies and anaerobic capacities after cold ischemia[J]. PLoS One, 2014, 9(6): e100609. DOI: 10.1371/journal.pone.0100609.
|
[23] |
ABUDHAISE H, TAANMAN JW, DEMUYLDER P, et al. Mitochondrial respiratory chain and Krebs cycle enzyme function in human donor livers subjected to end-ischaemic hypothermic machine perfusion[J]. PLoS One, 2021, 16(10): e0257783. DOI: 10.1371/journal.pone.0257783.
|
[24] |
MINOR T, STEGEMANN J, HIRNER A, et al. Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning[J]. Liver Transpl, 2009, 15(7): 798-805. DOI: 10.1002/lt.21751.
|
[25] |
SHI Q, SHEN Q, LIU Y, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance[J]. Cancer Cell, 2022, 40(10): 1207-1222. DOI: 10.1016/j.ccell.2022.08.012.
|
[26] |
SLADE L, BISWAS D, IHIONU F, et al. A lysosome independent role for TFEB in activating DNA repair and inhibiting apoptosis in breast cancer cells[J]. Biochem J, 2020, 477(1): 137-160. DOI: 10.1042/BCJ20190596.
|
[27] |
GUICCIARDI ME, MIYOSHI H, BRONK SF, et al. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications[J]. Am J Pathol, 2001, 159(6): 2045-2054. DOI: 10.1016/s0002-9440(10)63056-8.
|
[28] |
CHEN J, TANG YX, KANG JX, et al. Astragalus polysaccharide alleviates transport stress-induced heart injury in newly hatched chicks via ERS-UPR-autophagy dependent pathway[J]. Poult Sci, 2022, 101(9): 102030. DOI: 10.1016/j.psj.2022.102030.
|
[29] |
NOURI H, SHEIKHOLESLAMI-VATANI D, MOLOUDI MR. Changes in UPR-PERK pathway and muscle hypertrophy following resistance training and creatine supplementation in rats[J]. J Physiol Biochem, 2021, 77(2): 331-339. DOI: 10.1007/s13105-021-00801-4.
|
[30] |
VARIŞLI B, CAGLAYAN C, KANDEMIR FM, et al. The impact of Nrf2/HO-1, caspase-3/Bax/Bcl2 and ATF6/IRE1/PERK/GRP78 signaling pathways in the ameliorative effects of morin against methotrexate-induced testicular toxicity in rats[J]. Mol Biol Rep, 2022, 49(10): 9641-9649. DOI: 10.1007/s11033-022-07873-5.
|
[31] |
PARK J, CHO J, SONG EJ. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment[J]. Arch Pharm Res, 2020, 43(11): 1144-1161. DOI: 10.1007/s12272-020-01281-8.
|
[32] |
FOLCH-PUY E, PANISELLO A, OLIVA J, et al. Relevance of endoplasmic reticulum stress cell signaling in liver cold ischemia reperfusion injury[J]. Int J Mol Sci, 2016, 17(6): 807. DOI: 10.3390/ijms17060807.
|
[33] |
GARCIA D, SHAW RJ. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance[J]. Mol Cell, 2017, 66(6): 789-800. DOI: 10.1016/j.molcel.2017.05.032.
|
[34] |
PANISELLO-ROSELLÓ A, VERDE E, AMINE ZAOUALI M, et al. The relevance of the UPS in fatty liver graft preservation: a new approach for IGL-1 and HTK solutions[J]. Int J Mol Sci, 2017, 18(11): 2287. DOI: 10.3390/ijms18112287.
|
[35] |
ZAOUALI MA, BARDAG-GORCE F, CARBONELL T, et al. Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury[J]. Exp Mol Pathol, 2013, 94(2): 352-359. DOI: 10.1016/j.yexmp.2012.12.005.
|
[36] |
ZAOUALI MA, BONCOMPAGNI E, REITER RJ, et al. AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail[J]. J Pineal Res, 2013, 55(1): 65-78. DOI: 10.1111/jpi.12051.
|
[37] |
BEN MOSBAH I, ROSELLÓ-CATAFAU J, ALFANY-FERNANDEZ I, et al. Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation[J]. Liver Transpl, 2010, 16(2): 163-171. DOI: 10.1002/lt.21968.
|
[38] |
SUPURAN CT. Carbonic anhydrases-an overview[J]. Curr Pharm Des, 2008, 14(7): 603-614. DOI: 10.2174/138161208783877884.
|
[39] |
BEJAOUI M, PANTAZI E, DE LUCA V, et al. Carbonic anhydrase protects fatty liver grafts against ischemic reperfusion damage[J]. PLoS One, 2015, 10(7): e0134499. DOI: 10.1371/journal.pone.0134499.
|
[40] |
BEJAOUI M, PANTAZI E, DE LUCA V, et al. Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury[J]. J Pharmacol Exp Ther, 2015, 355(2): 191-198. DOI: 10.1124/jpet.115.225177.
|
[41] |
CHEN CH, FERREIRA JC, GROSS ER, et al. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities[J]. Physiol Rev, 2014, 94(1): 1-34. DOI: 10.1152/physrev.00017.2013.
|
[42] |
PANISELLO-ROSELLÓ A, ALVA N, FLORES M, et al. Aldehyde dehydrogenase 2 (ALDH2) in rat fatty liver cold ischemia injury[J]. Int J Mol Sci, 2018, 19(9): 2479. DOI: 10.3390/ijms19092479.
|
[43] |
BARDALLO RG, COMPANY-MARIN I, FOLCH-PUY E, et al. PEG35 and glutathione improve mitochondrial function and reduce oxidative stress in cold fatty liver graft preservation[J]. Antioxidants (Basel), 2022, 11(1): 158. DOI: 10.3390/antiox11010158.
|
[44] |
MAINES MD. New developments in the regulation of heme metabolism and their implications[J]. Crit Rev Toxicol, 1984, 12(3): 241-314. DOI: 10.3109/10408448409021604.
|
[45] |
NAITO Y, TAKAGI T, HIGASHIMURA Y. Heme oxygenase-1 and anti-inflammatory M2 macrophages[J]. Arch Biochem Biophys, 2014, 564: 83-88. DOI: 10.1016/j.abb.2014.09.005.
|
[46] |
KIM SJ, PARK JG, LEE SM. Protective effect of heme oxygenase-1 induction against hepatic injury in alcoholic steatotic liver exposed to cold ischemia/reperfusion[J]. Life Sci, 2012, 90(5/6): 169-176. DOI: 10.1016/j.lfs.2011.10.003.
|
[47] |
ZAOUALÍ MA, REITER RJ, PADRISSA-ALTÉS S, et al. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury[J]. J Pineal Res, 2011, 50(2): 213-221. DOI: 10.1111/j.1600-079X.2010.00831.x.
|
[48] |
ZAOUALÍ MA, PANISELLO A, LOPEZ A, et al. Cross-talk between sirtuin 1 and high-mobility box 1 in steatotic liver graft preservation[J]. Transplant Proc, 2017, 49(4): 765-769. DOI: 10.1016/j.transproceed.2017.01.071.
|